1Frank RN. Potential new medical therapies for diabetic retinopathy:protein kinase C inhibitors. Am J Ophthalmol, 2002,133:693-698. 被引量：1
2Qaum T, Xu QW, Joussen AM, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci,2001,42:2408-2413. 被引量：1
3Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoformselective inhibitor. Diabetes, 1997, 46:1473-1480. 被引量：1
7Joussen AM, Murata T, Tsujikawa A, et al. Leukocyte-mediated endothelial cell injury and death in the diabetic retina[J]. Am J Pathol, 2001,158:147-152. 被引量：1
8Serra AM, Waddell J, Manivannau A, et al. CDllb+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation [J]. Am J Pathol, 2012,181:719-727. 被引量：1
9Li G, Veenstra AA, Talahalli RR, et al. Marrow-derived cells regulate the development of early diabetic retinopathy and tactile allodynia in mice [J]. Diabetes, 2012,61:3294-3303. 被引量：1
10Haddad JJ, Harb HL. Cytokines and the regulation of hypoxia-inducible factor (HIF)-lalpha [J]. Int Immunopharmacol, 2005,5:461-483. 被引量：1
